Unconventional Myosin-Xviiia (MYO18A) Antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Unconventional Myosin-Xviiia (MYO18A) Antibody is a Mouse Monoclonal antibody for the detection of Unconventional Myosin-Xviiia (MYO18A) in Human samples.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | Unconventional Myosin-Xviiia (MYO18A) |
Host | Mouse |
Reactivity | Human |
Clonality | Monoclonal |
Conjugation | Unconjugated |
Isotype | IgG1 Kappa |
Clone ID | A232 |
Purity | > 95% |
Purification | Purified by Protein A/G affinity chromatography. |
Size 1 | 50 µg |
Size 2 | 100 µg |
Form | Liquid |
Tested Applications | FCM |
Buffer | 0.01 M PBS, pH 7.4. |
Availability | Shipped within 5-12 working days. |
Storage | Store at 4 °C if the entire vial will be used within 1 week. Aliquot and store at -20 °C or -80 °C for long-term storage. Avoid repeated freeze-thaw cycles. |
Dry Ice | No |
UniProt ID | Q92614 |
Gene ID | 399687 |
NCBI Accession | NP_001333696.1 |
Background | Antibody anti-MYO18A |
Status | RUO |
Note | Concentration: 1 mg/ml - |
Descripción
Related Products

MYO18A antibody
May link Golgi membranes to the cytoskeleton and participate in the tensile force required for vesicle budding from the Golgi. Thereby, may play a role in Golgi membrane trafficking and could indirectly give its flattened shape to the Golgi apparatus. Alternatively, in concert with LURAP1 and CDC42BPA/CDC42BPB, has been involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. May be involved in the maintenance of the stromal cell architectures required for cell to cell contact.
Ver Producto
MYO18A antibody
Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation.
Ver Producto